GOVX
Quality Rating
GOVX, a biotechnology company focused on vaccine development, exhibits strong compliance in debt and non-permissible income ratios but fails liquidity thresholds across major standards, leading to non-compliance in Shariah indexes. Business activities in healthcare R&D are permissible, with low ESG risks. Overall, the stock is classified as non-compliant due to zero index inclusions, though regional variations exist. Purification is required at 3.84% for interest income. Investors should monitor financial improvements for potential future compliance.
Purification Required
Moderate purification required - consider carefully
Index Inclusion
Not included in any major Shariah-compliant indexes
Key Compliance Considerations
- Liquidity ratio exceeds 30-33% thresholds across AAOIFI, MSCI, and S&P standards
- High cash holdings relative to market cap may indicate interest-bearing assets
Debt Ratio
0.0%
Liquidity Ratio
50.2%
Interest Income Ratio
3.8%
Purification
3.84%